← Leaderboards
Ju Dong Yang
Cedars-Sinai Medical Center
$1,024,837
Attributed
$1,243,073
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $705.3K · FY2022–24$1M$750K$500K$250K$0
'22
'23
'24
Funding mix
By agency
NIH$1,243,073 · 2
By mechanism
K08$806,601 · 1
R21$436,472 · 1
Top collaborators
- Yazhen Zhu1 shared
Most similar at Cedars-Sinai Medical Center
Same institution · by research overlap
- Julia Y Ljubimova$11,374,096
- Edwin Melencio Posadas$4,564,053
- John S Yu$7,940,413
- Steven D Colquhoun$438,944
- Yong J Lee$5,697,287
Others in their field
Other Rising Stars on “Enrollment”
- Jeffrey Leintz · National Opinion Research Center$40,628,545
- Sabrina Paganoni · Massachusetts General Hospital$36,168,406
- Suma Babu · Massachusetts General Hospital$36,168,406
- Joan Grand · Mitre Corporation$32,826,287
- Julia Louise Moore Vogel · Scripps Research Institute, The$32,252,685
- Supriya Menezes · The Emmes Company, Llc$25,277,032
Research focus
EnrollmentFundingCouplesEarly DiagnosisEvaluationExtracellular VesiclesCessation Of LifeComplementChemoembolizationDigitalAftercareApplications GrantsBiomarker DevelopmentArea Under CurveBiomarker PanelAblationCirculating BiomarkersCommunicationCancer EpidemiologyCancer EtiologyBioinformaticsDetectionBiological MarkersGrant
Grant awards (4)
Novel circulating biomarker digital scores for assessing treatment response in liver cancer$268,867
K08 · FY2024 · CA · contact PI
Novel circulating biomarker digital scores for assessing treatment response in liver cancer$436,472
R21 · FY2023 · CA · contact PI
Novel circulating biomarker digital scores for assessing treatment response in liver cancer$268,867
K08 · FY2023 · CA · contact PI
Novel circulating biomarker digital scores for assessing treatment response in liver cancer$268,867
K08 · FY2022 · CA · contact PI